Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AXITINIB for Neoplasm: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 38 adverse event reports in the FDA FAERS database where AXITINIB was used for Neoplasm.

Most Reported Side Effects for AXITINIB

Side Effect Reports % Deaths Hosp.
Death 2,222 14.0% 2,212 148
Diarrhoea 2,187 13.8% 121 539
Fatigue 1,816 11.5% 102 340
Neoplasm progression 1,315 8.3% 354 236
Hypertension 1,146 7.2% 78 320
Off label use 1,075 6.8% 338 178
Nausea 955 6.0% 74 225
Decreased appetite 920 5.8% 123 283
Dysphonia 871 5.5% 55 184
Disease progression 768 4.8% 242 171
Blood pressure increased 756 4.8% 45 166
Weight decreased 695 4.4% 61 184
Asthenia 629 4.0% 81 232
Stomatitis 514 3.2% 44 107
Headache 504 3.2% 19 116

Other Indications for AXITINIB

Renal cancer (3,422) Renal cell carcinoma (2,447) Metastatic renal cell carcinoma (1,612) Clear cell renal cell carcinoma (480) Renal cancer metastatic (456) Neoplasm malignant (412) Product used for unknown indication (223) Renal cell carcinoma stage iv (176) Renal cancer stage iv (96) Metastases to lung (82)

Other Drugs Used for Neoplasm

BEVACIZUMAB (502) ATEZOLIZUMAB (404) CYCLOPHOSPHAMIDE (385) CARBOPLATIN (283) PACLITAXEL (267) NIVOLUMAB (219) OXALIPLATIN (185) PEMBROLIZUMAB (173) LENALIDOMIDE (171) DOXORUBICIN (150)

Related Pages

AXITINIB Full Profile All Neoplasm Drugs AXITINIB Demographics AXITINIB Timeline